| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |